PRAXIS PRECISION MEDICINES I's ticker is PRAX and the CUSIP is 74006W108. A total of 104 filers reported holding PRAXIS PRECISION MEDICINES I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,513,127 | +48.7% | 1,469,665 | 0.0% | 3.89% | +76.3% |
| Q2 2023 | $1,690,115 | +42.2% | 1,469,665 | 0.0% | 2.21% | +35.6% |
| Q1 2023 | $1,188,959 | -66.0% | 1,469,665 | 0.0% | 1.63% | -65.4% |
| Q4 2022 | $3,497,803 | -47.6% | 1,469,665 | -50.0% | 4.70% | -21.5% |
| Q3 2022 | $6,672,000 | -7.3% | 2,939,329 | 0.0% | 5.99% | -1.6% |
| Q2 2022 | $7,201,000 | -76.0% | 2,939,329 | 0.0% | 6.08% | -65.1% |
| Q1 2022 | $30,011,000 | -48.2% | 2,939,329 | 0.0% | 17.46% | -19.4% |
| Q4 2021 | $57,905,000 | +6.5% | 2,939,329 | 0.0% | 21.66% | +39.1% |
| Q3 2021 | $54,348,000 | +1.1% | 2,939,329 | 0.0% | 15.57% | +15.5% |
| Q2 2021 | $53,731,000 | -44.2% | 2,939,329 | 0.0% | 13.47% | -44.6% |
| Q1 2021 | $96,292,000 | -40.5% | 2,939,329 | 0.0% | 24.33% | -26.7% |
| Q4 2020 | $161,722,000 | – | 2,939,329 | – | 33.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,469,665 | $3,497,803 | 4.70% |
| Ally Bridge Group (NY) LLC | 630,584 | $1,500,790 | 1.46% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,855,989 | $6,797,254 | 1.35% |
| 72 Investment Holdings, LLC | 988,995 | $2,353,808 | 1.08% |
| MPM BioImpact LLC | 610,000 | $1,451,800 | 0.38% |
| Octagon Capital Advisors LP | 800,000 | $1,904,000 | 0.30% |
| PFM Health Sciences, LP | 2,777,467 | $6,610,371 | 0.24% |
| HARVARD MANAGEMENT CO INC | 778,517 | $1,852,870 | 0.23% |
| Eventide Asset Management | 3,518,062 | $8,372,988 | 0.16% |
| Artal Group S.A. | 1,200,000 | $2,856 | 0.16% |